National Medicare Coverage Policies For Genetic Tests Suggested By Insurers
This article was originally published in The Pink Sheet Daily
Executive Summary
In response to a CMS call for input on revising its list of potential candidates for national coverage determinations in Medicare, AHIP suggests the agency stop relying on local carriers to determine payment for genetic tests. Biopharmaceutical groups raise concerns that CMS may be signaling a move toward a new standard for Medicare coverage.